FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988933904> ?p ?o ?g. }

• W1988933904 endingPage "202" @default.
• W1988933904 startingPage "191" @default.
• W1988933904 abstract "Experiments were performed to characterize the pharmacology of SCH 206272 [(R,R)-1'[5-[(3,5-dichlorobenzoyl)methylamino]-3-(3,4-dichlorophenyl)-4(Z)-(methoxyimino)pentyl]-N-methyl-2-oxo-[1,4'bipiperidine]-3-acetamide] as a potent and selective antagonist of tachykinin (NK) NK(1), NK(2), and NK(3) receptors. SCH 206272 inhibited binding at human tachykinin NK(1), NK(2), and NK(3) receptors (K(i) = 1.3, 0.4, and 0.3 nM, respectively) and antagonized [Ca(2+)](i) mobilization in Chinese hamster ovary (CHO) cells expressing the cloned human tachykinin NK(1), NK(2), or NK(3) receptors. SCH 206272 inhibited relaxation of the human pulmonary artery (pK(b) = 7.7 +/- 0.3) induced by the tachykinin NK(1) receptor agonist, [Met-O-Me] substance P and contraction of the human bronchus (pK(b = 8.2 +/- 0.3) induced by the tachykinin NK(2) receptor agonist, neurokinin A. In isolated guinea pig tissues, SCH 206272 inhibited substance P-induced enhancement of electrical field stimulated contractions of the vas deferens, (pK(b = 7.6 +/- 0.2), NKA-induced contraction of the bronchus (pK(b) = 7.7 +/- 0.2), and senktide-induced contraction of the ileum. In vivo, oral SCH 206272 (0.1-10 mg/kg, p.o.) inhibited substance P-induced airway microvascular leakage and neurokinin A-induced bronchospasm in the guinea pig. In a canine in vivo model, SCH 206272 (0.1-3 mg/kg, p.o.) inhibited NK(1) and NK(2) activities induced by exogenous substance P and neurokinin A. Furthermore, in guinea pig models involving endogenously released tachykinins, SCH 206272 inhibited hyperventilation-induced bronchospasm, capsaicin-induced cough, and airway microvascular leakage induced by nebulized hypertonic saline. These data demonstrate that SCH 206272 is a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist. This compound may have beneficial effects in diseases thought to be mediated by tachykinins, such as cough, asthma, and chronic obstructive pulmonary disease." @default.
• W1988933904 created "2016-06-24" @default.
• W1988933904 creator A5005005325 @default.
• W1988933904 creator A5005757827 @default.
• W1988933904 creator A5009324586 @default.
• W1988933904 creator A5014159007 @default.
• W1988933904 creator A5017041562 @default.
• W1988933904 creator A5018023242 @default.
• W1988933904 creator A5024460960 @default.
• W1988933904 creator A5026769477 @default.
• W1988933904 creator A5027650431 @default.
• W1988933904 creator A5028161799 @default.
• W1988933904 creator A5037322902 @default.
• W1988933904 creator A5038925978 @default.
• W1988933904 creator A5046002593 @default.
• W1988933904 creator A5046195597 @default.
• W1988933904 creator A5049722112 @default.
• W1988933904 creator A5050510437 @default.
• W1988933904 creator A5052726523 @default.
• W1988933904 creator A5054893065 @default.
• W1988933904 creator A5059909613 @default.
• W1988933904 creator A5073299652 @default.
• W1988933904 creator A5085005649 @default.
• W1988933904 date "2002-08-01" @default.
• W1988933904 modified "2023-09-27" @default.
• W1988933904 title "SCH 206272: a potent, orally active tachykinin NK1, NK2, and NK3 receptor antagonist" @default.
• W1988933904 cites W1860985526 @default.
• W1988933904 cites W1966718922 @default.
• W1988933904 cites W1972291682 @default.
• W1988933904 cites W1978664632 @default.
• W1988933904 cites W1978700752 @default.
• W1988933904 cites W1980511439 @default.
• W1988933904 cites W1981662665 @default.
• W1988933904 cites W1982180136 @default.
• W1988933904 cites W1992033396 @default.
• W1988933904 cites W1994538257 @default.
• W1988933904 cites W1999823046 @default.
• W1988933904 cites W2000654130 @default.
• W1988933904 cites W2003441248 @default.
• W1988933904 cites W2016004241 @default.
• W1988933904 cites W2017588581 @default.
• W1988933904 cites W2019193671 @default.
• W1988933904 cites W2033136071 @default.
• W1988933904 cites W2041170624 @default.
• W1988933904 cites W2044302827 @default.
• W1988933904 cites W2055713447 @default.
• W1988933904 cites W2066537193 @default.
• W1988933904 cites W2068119455 @default.
• W1988933904 cites W2071970541 @default.
• W1988933904 cites W2074631079 @default.
• W1988933904 cites W2075899663 @default.
• W1988933904 cites W2087354425 @default.
• W1988933904 cites W2091303128 @default.
• W1988933904 cites W2106958943 @default.
• W1988933904 cites W2138409939 @default.
• W1988933904 cites W2148484236 @default.
• W1988933904 cites W2192541481 @default.
• W1988933904 cites W2416491601 @default.
• W1988933904 cites W2951411646 @default.
• W1988933904 doi "https://doi.org/10.1016/s0014-2999(02)02124-6" @default.
• W1988933904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12206858" @default.
• W1988933904 hasPublicationYear "2002" @default.
• W1988933904 type Work @default.
• W1988933904 sameAs 1988933904 @default.
• W1988933904 citedByCount "35" @default.
• W1988933904 countsByYear W19889339042012 @default.
• W1988933904 countsByYear W19889339042013 @default.
• W1988933904 countsByYear W19889339042014 @default.
• W1988933904 countsByYear W19889339042018 @default.
• W1988933904 countsByYear W19889339042023 @default.
• W1988933904 crossrefType "journal-article" @default.
• W1988933904 hasAuthorship W1988933904A5005005325 @default.
• W1988933904 hasAuthorship W1988933904A5005757827 @default.
• W1988933904 hasAuthorship W1988933904A5009324586 @default.
• W1988933904 hasAuthorship W1988933904A5014159007 @default.
• W1988933904 hasAuthorship W1988933904A5017041562 @default.
• W1988933904 hasAuthorship W1988933904A5018023242 @default.
• W1988933904 hasAuthorship W1988933904A5024460960 @default.
• W1988933904 hasAuthorship W1988933904A5026769477 @default.
• W1988933904 hasAuthorship W1988933904A5027650431 @default.
• W1988933904 hasAuthorship W1988933904A5028161799 @default.
• W1988933904 hasAuthorship W1988933904A5037322902 @default.
• W1988933904 hasAuthorship W1988933904A5038925978 @default.
• W1988933904 hasAuthorship W1988933904A5046002593 @default.
• W1988933904 hasAuthorship W1988933904A5046195597 @default.
• W1988933904 hasAuthorship W1988933904A5049722112 @default.
• W1988933904 hasAuthorship W1988933904A5050510437 @default.
• W1988933904 hasAuthorship W1988933904A5052726523 @default.
• W1988933904 hasAuthorship W1988933904A5054893065 @default.
• W1988933904 hasAuthorship W1988933904A5059909613 @default.
• W1988933904 hasAuthorship W1988933904A5073299652 @default.
• W1988933904 hasAuthorship W1988933904A5085005649 @default.
• W1988933904 hasConcept C118303440 @default.
• W1988933904 hasConcept C126322002 @default.
• W1988933904 hasConcept C134018914 @default.
• W1988933904 hasConcept C170493617 @default.
• W1988933904 hasConcept C185592680 @default.
• W1988933904 hasConcept C202871150 @default.

• next